BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

827 related articles for article (PubMed ID: 19573774)

  • 1. Quality of care indicators for prostate cancer: progress toward consensus.
    Miller DC; Saigal CS
    Urol Oncol; 2009; 27(4):427-34. PubMed ID: 19573774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the quality of prostate cancer care.
    Penson DF
    Curr Opin Urol; 2008 May; 18(3):297-302. PubMed ID: 18382239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring the quality of care for localized prostate cancer.
    Miller DC; Montie JE; Wei JT
    J Urol; 2005 Aug; 174(2):425-31. PubMed ID: 16006858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-care indicators for early-stage prostate cancer.
    Spencer BA; Steinberg M; Malin J; Adams J; Litwin MS
    J Clin Oncol; 2003 May; 21(10):1928-36. PubMed ID: 12743145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in quality of care for men with early-stage prostate cancer.
    Spencer BA; Miller DC; Litwin MS; Ritchey JD; Stewart AK; Dunn RL; Gay EG; Sandler HM; Wei JT
    J Clin Oncol; 2008 Aug; 26(22):3735-42. PubMed ID: 18669460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment choice and quality of care for men with localized prostate cancer.
    Miller DC; Spencer BA; Ritchey J; Stewart AK; Dunn RL; Sandler HM; Wei JT; Litwin MS
    Med Care; 2007 May; 45(5):401-9. PubMed ID: 17446826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States.
    Ritchey J; Gay EG; Spencer BA; Miller DC; Wallner LP; Stewart AK; Dunn RL; Litwin MS; Wei JT
    J Urol; 2012 Sep; 188(3):769-74. PubMed ID: 22818140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center.
    Blayney DW; McNiff K; Hanauer D; Miela G; Markstrom D; Neuss M
    J Clin Oncol; 2009 Aug; 27(23):3802-7. PubMed ID: 19487377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of quality indicators to evaluate the care of patients with localized prostate carcinoma.
    Miller DC; Litwin MS; Sanda MG; Montie JE; Dunn RL; Resh J; Sandler H; Wei JT
    Cancer; 2003 Mar; 97(6):1428-35. PubMed ID: 12627506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to prostate cancer by managed care organizations.
    Bennett CL; Buchner DA; Ullman M
    Urology; 1997 Jul; 50(1):79-86. PubMed ID: 9218023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate quality of care indicators for localized bladder cancer.
    Cooperberg MR; Porter MP; Konety BR
    Urol Oncol; 2009; 27(4):435-42. PubMed ID: 19573775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A process for measuring the quality of cancer care: the Quality Oncology Practice Initiative.
    Neuss MN; Desch CE; McNiff KK; Eisenberg PD; Gesme DH; Jacobson JO; Jahanzeb M; Padberg JJ; Rainey JM; Guo JJ; Simone JV
    J Clin Oncol; 2005 Sep; 23(25):6233-9. PubMed ID: 16087948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of prostate cancer quality indicators: a modified Delphi approach.
    Gagliardi AR; Fleshner N; Langer B; Stern H; Brown AD
    Can J Urol; 2005 Oct; 12(5):2808-15. PubMed ID: 16274516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of prostate carcinoma care in a statewide public assistance program.
    Krupski TL; Bergman J; Kwan L; Litwin MS
    Cancer; 2005 Sep; 104(5):985-92. PubMed ID: 16047332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National assessment of melanoma care using formally developed quality indicators.
    Bilimoria KY; Raval MV; Bentrem DJ; Wayne JD; Balch CM; Ko CY
    J Clin Oncol; 2009 Nov; 27(32):5445-51. PubMed ID: 19826131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The critical limitations of volume-outcome analysis.
    Ellison L
    Urol Oncol; 2009; 27(4):422-6. PubMed ID: 19573773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing performance measurement in oncology.
    Campion FX; Larson LR; Kadlubek PJ; Earle CC; Neuss MN
    Am J Manag Care; 2011 May; 17 Suppl 5 Developing():SP32-6. PubMed ID: 21711075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance measurement in prostate cancer care: beyond report cards.
    Ullman M; Metzger CK; Kuzel T; Bennett CL
    Urology; 1996 Mar; 47(3):356-65. PubMed ID: 8633402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using QRRO survey data to assess compliance with quality indicators for breast and prostate cancer.
    Owen JB; White JR; Zelefsky MJ; Wilson JF
    J Am Coll Radiol; 2009 Jun; 6(6):442-7. PubMed ID: 19467491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of quality indicators for patients undergoing colorectal cancer surgery.
    McGory ML; Shekelle PG; Ko CY
    J Natl Cancer Inst; 2006 Nov; 98(22):1623-33. PubMed ID: 17105985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.